Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,282.00
(
-0.98%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 108174

Friday, 07/27/2012 10:36:02 AM

Friday, July 27, 2012 10:36:02 AM

Post# of 257580
Lupin could be first US filer for generic Advair:

http://articles.economictimes.indiatimes.com/2012-07-26/news/32869722_1_vinita-gupta-lupin-pharma-generic-drug

This is a tricky approval to pull off because of the need to replicate the device as well as the drug; NVS and Teva both gave up on such a project despite the lure of Advair’s huge US sales.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today